Six hundred thousand doses of lifesaving COVID-19 vaccine from the UN-partnered COVAX initiative have arrived in Ghana.
Confirming the news on Wednesday, the World Health Organization (WHO) said that further supplies of the AstraZeneca/Oxford jab will reach Côte d’Ivoire later this week.
600,000 #COVID19 vaccines arrived in Accra this morning, making the country the first in Africa to receive the vaccines from COVAX facility. #VaccinEquity https://t.co/Nkp4sYQVRA
— World Health Organization (WHO) (@WHO) February 24, 2021
These are the first coronavirus shots from the COVAX scheme to be distributed outside India, where the vaccine is being produced under licence.
Further supplies will be shipped to the other members as the global rollout gathers pace, when readiness criteria have been met and the doses produced.
Only the beginning
Tedros Adhanom Ghebreyesus, the WHO Director General, welcomed the development, along with COVAX partners Gavi, the Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI).
But he insisted that there was still “a lot of work to do” to secure support for WHO’s goal of giving the vaccine to all health workers and older people in the first 100 days of the year.
“We will not end the pandemic anywhere unless we end it everywhere,” the WHO chief said in a joint statement.
“Today is a major first step towards realizing our shared vision of vaccine equity, but it’s just the beginning. We still have a lot of work to do with governments and manufacturers to ensure that vaccination of health workers and older people is underway in all countries within the first 100 days of this year.”
Vaccine development ‘crucial’
Echoing the urgent need for universal vaccine distribution, Dr Richard Hatchett, Chief Executive Officer at CEPI, noted that there were now “multiple safe and effective vaccines against COVID-19 developed in record time”.
But the “increased spread” of COVID-19 variants had ushered in a “new and less predictable phase of the pandemic”, Dr Hatchett insisted. “It is crucial that the vaccines we have developed are shared globally, as a matter of the greatest urgency, to reduce the prevalence of disease, slow down viral mutation, and bring the pandemic to an end.”
In an appeal for greater support for the initiative, which Dr Seth Berkley, head of fellow COVAX partner GAVI insisted that the delivery of vaccines to Ghana was a proud moment, but it had to be repeated “to all participating economies” in coming weeks, “to ensure that those most at risk are protected, wherever they live”.
Governments and businesses needed to “recommit” to COVAX, the Gavi chief insisted “and help us defeat this virus as quickly as possible”.
In order for new coronavirus doses to be delivered to COVAX participants, the criteria which need to be fulfilled include confirmation of national regulatory authorisations for the vaccine in question, national vaccination plans and export and import licences.
Decline in deaths
The development comes as WHO reported a drop in COVID-19 deaths for the third consecutive week.